Moneycontrol PRO

Hold Cipla; target of Rs 1080: Arihant Capital

Arihant Capital recommended hold rating on Cipla with a target price of Rs 1080 in its research report dated August 01, 2022.

August 02, 2022 / 06:41 PM IST
  • bselive
  • nselive
Todays L/H

Arihant Capital's research report on Cipla

Cipla Ltd. is an Indian pharmaceutical major with global presence across America, Europe and Emerging Market regions. It has a strong product portfolio in the respiratory segment. The company has a number of USFDA (United States Food and Drug Administration) compliant plant facilities which supply formulations to the international market.


Factoring the future growth opportunities, we value the company at a P/E Multiple of 25x its FY24E EPS of INR 43.2 and arrive at a Target Price of INR 1,080 per share. Accordingly, we recommend a Hold rating on the shares of Cipla Ltd.


For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on are their own, and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.

Cipla -010822 - arih

Broker Research
first published: Aug 2, 2022 06:41 pm
ISO 27001 - BSI Assurance Mark